Addressing Exosome Manufacturing Needs
Exosomes are nanoscale extracellular vesicles essential for cell-to-cell communication and therapeutic delivery. As regenerative medicine and cell therapy advance, exosome manufacturing has become a cornerstone for developing next-generation treatments.
However, the journey from concept to clinic is complex. Manufacturing exosomes for clinical and commercial use requires:
- Efficient high-quality exosome production: Ensuring consistency, scalability, and purity for research, clinical, and commercial supply.
- Maintaining exosome integrity and potency: Robust processes for isolation, purification, and storage are critical to preserve therapeutic efficacy.
- Navigating regulatory and quality requirements: Meeting global standards for GMP, documentation, and traceability.
Cellipont Bioservices is dedicated to overcoming these challenges. Our advanced exosome manufacturing services support innovators at every stage, from early development through commercialization. We combine technical expertise, state-of-the-art facilities, and a collaborative approach to accelerate your program and maximize patient impact.
Our Capabilities
Cellipont Bioservices supports a diverse range of exosome manufacturing programs, including:
- Process Development: Custom protocols for exosome isolation, purification, and characterization.
- Scalable GMP Manufacturing: Flex Suites designed for seamless scale-up from preclinical to commercial volumes.
- Quality Control: Advanced analytics for exosome purity, potency, and safety.
- Technology Integration: Support for various cell sources, including allogeneic and autologous platforms.
- Regulatory Support: Documentation and guidance for IND and BLA submissions.
Our manufacturing capabilities are built on flexibility and scalability, ensuring seamless transition from clinical development to commercial production.
Key Capabilities
Our team’s expertise in exosome manufacturing ensures your program benefits from best-in-class science, technology, and operational excellence.
GMP & Regulatory Compliance
Quality and compliance are at the heart of Cellipont’s manufacturing philosophy. We adhere to the highest global standards, including:
- GMP (Good Manufacturing Practice): Rigorous protocols for facility management, documentation, and process control.
- FDA & EMA Compliance: Systems designed to meet the requirements of major regulatory agencies, supporting global product registration and commercialization.
Our dedicated quality assurance team ensures every batch meets stringent specifications, giving clients confidence in product safety, efficacy, and regulatory readiness.
Why Choose Cellipont Bioservices
Choosing the right manufacturing partner is critical for the success of your exosome therapy program. Here’s why Cellipont stands out:
Proven Track Record
Decades of experience supporting clinical and commercial advanced therapy programs.
Collaborative Approach
We work as an extension of your team, providing transparent communication and proactive problem-solving.
Technical Excellence
Our scientists and engineers are leaders in exosome manufacturing, process development, and regulatory strategy.
Flexible Solutions
Customizable services to meet the unique needs of each client and therapy.
End-to-End Support
From cell sourcing to final product release, we manage every aspect of the manufacturing process.
What Our Customers Are Saying
"Cellipont’s world-class facility and deep expertise in cGMP manufacturing for cell and gene therapies make them an ideal manufacturing partner and align perfectly with our mission to deliver transformative therapies for cardiovascular diseases and beyond."
Ready to take the next step in exosomes manufacturing?
Connect with Cellipont Bioservices today and discover how our expertise can accelerate your program and deliver life-changing therapies to patients worldwide.
Let’s work together